FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4221009863> ?p ?o ?g. }

• W4221009863 endingPage "953" @default.
• W4221009863 startingPage "940" @default.
• W4221009863 abstract "The introduction of next-generation sequencing into the diagnosis of neuromuscular disorders has resulted in an increased number of newly identified RYR1 variants. The hypothesis was that there is an increased referral of patients to malignant hyperthermia units without a personal/family history of adverse anesthetic events suspected to be malignant hyperthermia. This retrospective multicenter cohort study evaluates patient referral indications and outcomes for those without a history of an adverse anesthetic event.Patients referred between 2010 and 2019 to the malignant hyperthermia units in Antwerp, Belgium; Lund, Sweden; Nijmegen, The Netherlands; and Toronto, Ontario, Canada were included. Previously tested patients and relatives of previously tested patients were excluded. Data collection included demographics, referral details, muscle contracture, and genetic testing results including Rare Exome Variant Ensemble Learner scores. Referral indications were categorized into those with a personal/family history of adverse anesthetic event and other indications including exertional and/or recurrent rhabdomyolysis, RYR1 variant(s) detected in diagnostic testing in the neuromuscular clinic without a specific diagnosis (in a family member), diagnosed RYR1-related myopathy (in a family member), idiopathically elevated resting creatine kinase values, exertional heat stroke, and other.A total of 520 medical records were included, with the three most frequent referral indications as follows: personal history of an adverse anesthetic event (211 of 520; 40.6%), family history of an adverse anesthetic event (115 of 520; 22.1%), and exertional and/or recurrent rhabdomyolysis (46 of 520; 8.8%). The proportion of patients referred without a personal/family history of an adverse anesthetic event increased to 43.6% (133 of 305) between 2015 and 2019 compared to 28.4% (61 of 215) in 2010 to 2014 (P < 0.001). Patients with a personal/family history of an adverse anesthetic event were more frequently diagnosed as malignant hyperthermia-susceptible (133 of 220; 60.5%) than those without (47 of 120; 39.2%; P < 0.001). Due to missing data, 180 medical records were excluded.The proportion of patients referred to malignant hyperthermia units without a personal/family history of an adverse anesthetic event has increased, with 39.2% (47 of 120) diagnosed as malignant hyperthermia-susceptible." @default.
• W4221009863 created "2022-04-03" @default.
• W4221009863 creator A5001793690 @default.
• W4221009863 creator A5005171481 @default.
• W4221009863 creator A5006750750 @default.
• W4221009863 creator A5012105654 @default.
• W4221009863 creator A5014631278 @default.
• W4221009863 creator A5016497325 @default.
• W4221009863 creator A5031997713 @default.
• W4221009863 creator A5037012363 @default.
• W4221009863 creator A5044623863 @default.
• W4221009863 creator A5087332579 @default.
• W4221009863 date "2022-03-14" @default.
• W4221009863 modified "2023-10-11" @default.
• W4221009863 title "Referral Indications for Malignant Hyperthermia Susceptibility Diagnostics in Patients without Adverse Anesthetic Events in the Era of Next-generation Sequencing" @default.
• W4221009863 cites W1884824544 @default.
• W4221009863 cites W1901419121 @default.
• W4221009863 cites W1991203132 @default.
• W4221009863 cites W2000931006 @default.
• W4221009863 cites W2010766270 @default.
• W4221009863 cites W2022764001 @default.
• W4221009863 cites W2027803552 @default.
• W4221009863 cites W2035808268 @default.
• W4221009863 cites W2047664621 @default.
• W4221009863 cites W2072306307 @default.
• W4221009863 cites W2072931441 @default.
• W4221009863 cites W2087955851 @default.
• W4221009863 cites W2112906555 @default.
• W4221009863 cites W2138251630 @default.
• W4221009863 cites W2161515375 @default.
• W4221009863 cites W2172062766 @default.
• W4221009863 cites W2307347081 @default.
• W4221009863 cites W2334524426 @default.
• W4221009863 cites W2346414314 @default.
• W4221009863 cites W2511076828 @default.
• W4221009863 cites W2521967673 @default.
• W4221009863 cites W2603775707 @default.
• W4221009863 cites W2754238359 @default.
• W4221009863 cites W2949560087 @default.
• W4221009863 cites W2956325081 @default.
• W4221009863 cites W3006005147 @default.
• W4221009863 cites W3087837216 @default.
• W4221009863 cites W3097775181 @default.
• W4221009863 cites W3138505755 @default.
• W4221009863 cites W3167515525 @default.
• W4221009863 cites W3188079665 @default.
• W4221009863 cites W3195622434 @default.
• W4221009863 cites W4226424475 @default.
• W4221009863 cites W4248197639 @default.
• W4221009863 cites W4313371759 @default.
• W4221009863 doi "https://doi.org/10.1097/aln.0000000000004199" @default.
• W4221009863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35285867" @default.
• W4221009863 hasPublicationYear "2022" @default.
• W4221009863 type Work @default.
• W4221009863 citedByCount "8" @default.
• W4221009863 countsByYear W42210098632022 @default.
• W4221009863 countsByYear W42210098632023 @default.
• W4221009863 crossrefType "journal-article" @default.
• W4221009863 hasAuthorship W4221009863A5001793690 @default.
• W4221009863 hasAuthorship W4221009863A5005171481 @default.
• W4221009863 hasAuthorship W4221009863A5006750750 @default.
• W4221009863 hasAuthorship W4221009863A5012105654 @default.
• W4221009863 hasAuthorship W4221009863A5014631278 @default.
• W4221009863 hasAuthorship W4221009863A5016497325 @default.
• W4221009863 hasAuthorship W4221009863A5031997713 @default.
• W4221009863 hasAuthorship W4221009863A5037012363 @default.
• W4221009863 hasAuthorship W4221009863A5044623863 @default.
• W4221009863 hasAuthorship W4221009863A5087332579 @default.
• W4221009863 hasBestOaLocation W42210098631 @default.
• W4221009863 hasConcept C113217602 @default.
• W4221009863 hasConcept C126322002 @default.
• W4221009863 hasConcept C187212893 @default.
• W4221009863 hasConcept C197934379 @default.
• W4221009863 hasConcept C206179267 @default.
• W4221009863 hasConcept C2776135927 @default.
• W4221009863 hasConcept C2776333580 @default.
• W4221009863 hasConcept C2778575482 @default.
• W4221009863 hasConcept C2779379848 @default.
• W4221009863 hasConcept C2781179581 @default.
• W4221009863 hasConcept C42219234 @default.
• W4221009863 hasConcept C512399662 @default.
• W4221009863 hasConcept C519063684 @default.
• W4221009863 hasConcept C71924100 @default.
• W4221009863 hasConceptScore W4221009863C113217602 @default.
• W4221009863 hasConceptScore W4221009863C126322002 @default.
• W4221009863 hasConceptScore W4221009863C187212893 @default.
• W4221009863 hasConceptScore W4221009863C197934379 @default.
• W4221009863 hasConceptScore W4221009863C206179267 @default.
• W4221009863 hasConceptScore W4221009863C2776135927 @default.
• W4221009863 hasConceptScore W4221009863C2776333580 @default.
• W4221009863 hasConceptScore W4221009863C2778575482 @default.
• W4221009863 hasConceptScore W4221009863C2779379848 @default.
• W4221009863 hasConceptScore W4221009863C2781179581 @default.
• W4221009863 hasConceptScore W4221009863C42219234 @default.
• W4221009863 hasConceptScore W4221009863C512399662 @default.
• W4221009863 hasConceptScore W4221009863C519063684 @default.
• W4221009863 hasConceptScore W4221009863C71924100 @default.
• W4221009863 hasIssue "6" @default.

• next